Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Consolidated Statements Of Operations [Abstract]
Net sales	$ 316,199	$ 333,607	$ 582,150	$ 603,985
Cost of goods sold:
Cost of sales	170,757	188,762	325,647	350,088
Depreciation related to cost of goods sold	1,514	1,960	3,069	3,959
Total cost of goods sold	172,271	190,722	328,716	354,047
Gross profit	143,928	142,885	253,434	249,938
Operating expenses:
Selling, general and administrative	131,757	180,205	241,432	294,070
Depreciation and amortization	9,170	10,795	18,685	21,508
Total operating expenses	140,927	191,000	260,117	315,578
Income (loss) from operations	3,001	(48,115)	(6,683)	(65,640)
Other expense
Interest expense, net	7,759	7,712	15,020	15,468
Debt extinguishment charges		239		239
Other expense, net	7,759	7,951	15,020	15,707
Loss before income taxes	(4,758)	(56,066)	(21,703)	(81,347)
Provision for income taxes	1,513	833	904	1,057
Net loss	(6,271)	(56,899)	(22,607)	(82,404)
Net loss attributable to noncontrolling interests (See Note 5)	(1,329)	(760)	(1,729)	(915)
Net loss attributable to Elizabeth Arden shareholders	(4,942)	(56,139)	(20,878)	(81,489)
Less: Accretion and dividends on preferred stock (See Note 12)	669	639	1,313	21,085
Net loss attributable to Elizabeth Arden common shareholders	$ (5,611)	$ (56,778)	$ (22,191)	$ (102,574)
Net loss per common share attributable to Elizabeth Arden common shareholders:
Basic	$ (0.19)	$ (1.90)	$ (0.74)	$ (3.44)
Diluted	$ (0.19)	$ (1.90)	$ (0.74)	$ (3.44)
Weighted average number of common shares:
Basic	29,921	29,812	29,875	29,796
Diluted	29,921	29,812	29,875	29,796